Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Clinical trial NCT07481734 · RECRUITING

Trial details

NCT number: NCT07481734
Sponsor: Hudson Biotech
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Associated Steatotic Liver Disease Nonalcoholic Steatohepatitis Hepatic Steatosis

Start date: 2026-02-02
Primary completion: 2027-02-14
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.